Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)

Capital Expenditure

-$32.00M

Quarterly · Period ending: · USD

BIO logo

BIO Capital Expenditure

Latest reported-$32.00M
BIO Quarterly CapEx (-$3.30M → -$32.00M)
High-resolution chart · PNG

BIO capital expenditure history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bio-Rad Laboratories, Inc. Class A Common Stock Capital Expenditure — Quarterly (USD)
Period endingCapital Expenditure (USD)
-32,000,000
-30,000,000
-45,800,000
-31,700,000
-45,700,000
-34,400,000
-42,904,000
-63,639,000
-42,281,000
-40,176,000
-42,245,000
-44,071,000
-34,639,000
-35,725,000
-46,933,000
-27,575,000
-17,334,000
-33,078,000
-43,240,000
-34,628,000
-23,388,000
-19,547,000
-39,135,000
-19,978,000
-18,116,000
-21,691,000
-21,598,000
-31,091,000
-22,214,000
-23,629,000
-53,874,000
-22,054,000
-26,716,000
-27,184,000
-26,073,000
-20,183,000
-29,539,000
-39,332,000
-45,242,000
-39,458,000
-31,575,000
-25,296,000
-27,984,000
-24,798,000
-32,203,000
-28,387,000
-40,125,000
-27,461,000
-33,953,000
-34,939,000
-29,842,000
-20,340,000
-24,532,000
-34,566,000
-40,107,000
-37,160,000
-42,031,000
-34,899,000
-35,652,000
-24,972,000
-24,788,000
-17,912,000
-32,872,000
-21,076,000
-19,815,000
-18,090,000
-20,000,000
-17,606,000
-20,088,000
-18,667,000
-22,680,000
-25,870,000
-20,539,000
-19,720,000
-14,657,000
-18,668,000
-18,034,000
-11,311,000
-14,908,000
-13,228,000
-13,533,000
-11,318,000
-9,758,000
-8,706,000
-7,817,000
-9,774,000
-18,866,000
-12,570,000
-15,640,000
-13,417,000
-21,332,000
-22,303,000
-14,387,000
-10,981,000
-10,966,000
-12,284,000
-10,531,000
-8,443,000
-11,158,000
-12,419,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.